Be ready when that next lymphoma case enters your exam room.
The options for canine lymphoma patients have never been better, and primary care veterinary teams can now provide a lot more than prednisone. Learn what you can do for lymphoma patients before they ever see a specialist, how to communicate with clients about cancer, and how a new class of drugs is changing the game.
WHAT YOU’LL LEARN
• Recommended diagnostics that can inform tailored treatment protocols
• An oncologist’s advice for talking to clients about a cancer diagnosis and treatment options
• When and how to start treating lymphoma patients in your practice
• What to do for patients waiting to see a specialist
• How the new SINE class of drugs work
*This program is pending approval for 1 hour of CE credit in the jurisdictions that recognize RACE approval.
Join Lone Star Veterinary Academy and accomplished Veterinary Oncologist, Avenelle Turner, DVM, DACVIM (Oncology), on July 25 to discuss a new clinical breakthrough in therapy for canine lymphoma! In this one-hour session, we will review the diagnosis, prognosis, and treatment of lymphoma, before diving into an eye-opening discussion on a novel class of chemotherapeutic drugs: SINE Inhibitors. We’ll study the mechanism of action, efficacy, adverse effects, and clinical utility for your practice. Invite your whole team to listen live and learn about this promising new option for treating canine lymphoma.
Highlights
Inclusions
This program has been approved for 1.0 hour of continuing education credit in jurisdictions that recognize RACE approval.
Wish you could do more for your canine lymphoma patients? Good news: Best practices for diagnosing and treating canine lymphoma are moving forward at a rapid pace, and general practitioners can do more than ever to help dogs with lymphoma.
Join veterinary oncologist Dr. Craig Clifford, director of clinical studies at Hope Veterinary Specialists/BluePearl Malvern, for this 1-hour CE session to learn about a novel treatment option, LAVERDIA-CA1, and how it may fit in at your clinic. We’ll also review the latest techniques for staging and grading lymphoma—and share tips for collaborating with your local specialist on a treatment plan.
Note: The following educational and training sessions have been previously recorded and do not count for any continuing education (CE) credits. They are informational recordings from previous presentations that provide valuable information about diagnosing lymphoma and incorporating LAVERDIA™-CA1 into your practice.
The diagnosis and treatment of canine lymphoma is moving forward at an increasingly rapid pace. In this session, you will:
Learn how to diagnose, stage, and grade canine lymphoma
Learn the importance of phenotyping
Explore the role of chemotherapy and protocol selection in naïve and relapse cases
Review new treatment options
DVM, DACVIM (SAIM, Oncology)
Assistant Professor of Oncology
Iowa State University
DVM, MS, DACVIM (Oncology)
Director of Clinical Studies
Hope Veterinary Specialists / BluePearl Malvern
DVM, MS, PhD, DACVIM (Oncology)
Director of Clinical Studies
VCA
The following education sessions, presented by Dan Dreyfuss, DVM, Veterinary Technical Services Manager at Anivive, were intended for veterinary professionals. Attendees learned more about LAVERDIA™-CA1, the first FDA conditionally approved oral tablet to treat lymphoma in dogs. You can watch the recordings below.
